The adherence of Greek chest physicians to CAP Guidelines: The role of patient-related factors
More details
Hide details
1st Department of Respiratory Medicine, Medical School, National and Kapodistrian University of Athens, “SOTIRIA” Chest Diseases Hospital, Athens, Greece
2nd Department of Pneumonology Medicine, Medical School, National and Kapodistrian University of Athens, “ATTIKON” University Hospital, Haidari, Greece
Department of Information Management, School of Management and Economics, Technological Educational Institute of Kavala, Kavala, Greece
3rd Department of Internal Medicine, Medical School, National and Kapodistrian University of Athens, “SOTIRIA” Chest Diseases Hospital, Athens, Greece
Anna Karakatsani   

2nd Department of Pneumonology Medicine, National and Kapodistrian University of Athens, “ATTIKON” University Hospital, 1 Rimini Street, 12462 Haidari, Greece
Pneumon 2011;24(4):361–367
Multiple international studies have shown that the adherence of chest physicians to guidelines is variable. In Greece there is lack of information on this subject. An epidemiological study was conducted to evaluate the temporal trends of the adherence to guidelines of Greek chest physicians. Retrospective assessment was made of their degree of adherence to international guidelines for the management of patients hospitalized for community acquired pneumonia (CAP) and the patient-related factors that influence this.

The medical records were studied of 80 randomly selected patients admitted to the Chest Diseases Hospital of Athens in the first 6 months of 2000 with a presumptive diagnosis of CAP. Epidemiological and clinical data and information on admission criteria, diagnostic procedures and antibiotic treatment were collected from those fulfilling the diagnostic criteria for CAP. The appropriateness of the recorded procedures and treatment was evaluated in comparison to the CAP guidelines that were in use during the study period. Odds ratios (OR) for associated factors were calculated (the lower the OR value the lower the degree of adherence).

During the study period 67 eligible patients, with a mean age of 58.8 years, were identified. The rate of diagnostic procedures ranged from 100% for chest X-ray to 12% for blood culture. About 71% of patients had received appropriate antibiotic treatment on admission. An age of above than 70 years, altered mental status, aspiration, respiratory failure and multilobar pneumonia were found to be significant predictors of inappropriate therapy with ORs of 0.2 (95% CI: 0.1- 0.6, p=0.004), 0.04 (95% CI: 0-0.4, p=0.004), 0.04 (95% CI: 0-0.3, p=0.002), 0.3 (95% CI: 0-0.87, p=0.02), and 0.1 (95% CI:0.04-0.50, p=0.001) respectively. Aspiration was the most important factor for non-adherence on multivariate analysis adjusted for age (OR:0.05, 95% CI: 0.005-0.45, p=0.008).

The adherence to CAP management guidelines was not grossly unsatisfactory but room for improvement was revealed.

Mandell LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. CID 2007; 44 (Suppl 2): S27-S72.
Menéndez R, Reyes S, Martínez R, de la Cuadra P, Manuel Vallés J, Vallterra J. Economic evaluation of adherence to treatment guidelines in nonintensive care pneumonia. Eur Respir J 2007; 29: 751-756.
Mandell LA, Bartlett JG, Dowell SF, et al. Update of Practice guidelines for the management of community-acquired pneumonia in immunocompetent adults. CID 2003; 37: 1405-1433.
Niederman MS, Bass JB, Campbell GD, et al. Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy. Am Rev Respir Dis 1993; 148: 1418-1426.
Barlett JG, Breiman RF, Mandell LA, File TM Jr. Communityacquired pneumonia in adults: guidelines for management. Clin Infect Dis 1998; 26: 811-838.
Bernstein JM. Treatment of Community-Acquired PneumoniaIDSA Guidelines. Chest 1999; 115: 9S-13S.
The British Thoracic Society. Guidelines for the management of community-acquired pneumonia in adults admitted to the hospital. BJHM 1993; 49: 346-350.
Niederman MS. Guidelines for the management of communityacquired pneumonia. Current Recommendations and antibiotic selection issues. Med Clin North Am 2001; 85: 1493-1509.
ERS Task force. Guidelines for management of adult community-acquired lower respiratory tract infections. Eur Resp J 1998;11:986-991.
Menéndez R, Ferrando D, Vallés JM, Vallterra J. Influence of deviation from guidelines on the outcome of communityacquired pneumonia. Chest 2002; 122: 612-617.
Dean NC, Silver MP, Bateman KA, James B, Hadlock CJ, Hale D. Decreased mortality after implementation of a treatment guideline for community-acquired pneumonia. Am J Med 2001; 110: 451-457.
Blasi F, Iori I, Bulfoni A, Corrao S, Constantino S, Legnani D. Can CAP guideline adherence improve patient outcome in internal medicine departments? Eur Respir J 2008; 32: 902-910.
Gleason PP, Kapoor WN, Stone RA, et al. Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with Community-acquired pneumonia. JAMA 1997; 278: 32-39.
Gleason PP, Meehan TP, Fine JM, Galusha DH, Fine MJ. Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia. Arch Intern Med 1999; 159: 2562-2572.
Feagan B, Marrie T, Lau C, Wheeler SL, Wong CJ, Vandervoort MK. Treatment and outcomes of community-acquired pneumonia at Canadian hospitals. CMAJ 2000; 162: 1415-20.
Marras TK, Chan CK. Use of guidelines in treating community acquired pneumonia. Chest 1998; 113: 1689-94.
Ali MH, Kalima P, Maxwell SRJ. Failure to implement hospital antimicrobial prescribing guidelines: a comparison of two UK academic centers. JAC 2006; 57: 959-962.
Menéndez R, Torres A, Zalacaín R, et al. Guidelines for the treatment of community-acquired pneumonia. Predictors of adherence and outcome. Am J Respir Crit Care Med 2005; 172: 757-762.
Dambrava PG, Torres A, Vallès X, et al. Adherence to guidelines’ empirical antibiotic recommendations and community-acquired pneumonia outcome. Eur Respir J 2008; 32: 892-901.
Ruiz M, Ewig S, Marcos MA, et al. Etiology of community acquired pneumonia: Impact of age, comorbidity and severity. Am J Respir Crit Care Med 1999; 397-405.
Jencks SF, Curedon T, Burwen DR, et al. Quality of medical care delivered to Medicare beneficiaries: A profile at State and National Levels. JAMA 2000; 284: 1670-1676.
Switzer G, Halm E, Chang CC, Mihman BS, Walsh MB, Fine MJ. Physician awareness and self reported use of local and national guidelines for community acquired pneumonia. J Gen Intern Med 2003; 18: 816-823.
Tunis SR, Hayward R, Wilson M, et al. Internists’ Attitudes about Clinical Practice Guidelines. Annals Int Med 1994; 120: 956-963.
Keeley D. Guidelines for managing community-acquired pneumonia in adults. BMJ 2002; 324: 436-437.
Robinson T. Compliance is limited by opposing recommendations. (Letter) BMJ 2002; 324: 1159.
Gilbert K, Gleason PP, Singer DE, et al. Variations in antimicrobial use and cost in more than 2000 patients with community acquired pneumonia. Am J Med 1998; 104: 17-27.
Diaz A, Kuzmanic G, Platzer L, Sanfuentes F, Espinosa MA, Saldías F. Medical outcomes and antimicrobial compliance according to the Chilean Society of Respiratory Diseases guidelines for hospitalized patients with community acquired pneumonia. Rev Med Chil 2003; 131: 847-56.
Wu JH, Howard DH, McGowan JE Jr, Turpin RS, Henry Hu X. Adherence to Infectious Diseases Society of America Guidelines for Empiric therapy for patients with community-acquired pneumonia in commercially insured cohort. Clin Ther 2006; 28: 1451-1461.
Kanavaki S, Karabela S, Makarona M, Moraiti H, Koumantakis P, Refanis A. Current tnimicrobial resistance of pneumococcus. Pneumon 2005; 18:263-274.
Poulakou G, Katsarolis I, Mattaiopoulou I, et al. Nationwide surveillance of Streptococcus pneumoniae in Greece: patterns of resistance and serotype epidemiology. Int J Antimicrob Agents 2007; 30: 87-92.
Souli M, Volonakis K, Kapaskelis A, et al. Characterisation of macrolide non-susceptible S. pneumoniae colonizing children in attending day-care centers in Athens, Greece during 2000 and 2003. Clin Microbiol Infect 2007; 13: 70-77.
Corbo J, Friedman B, Bijur P, et al. Limited usefulness of initial blood cultures in community-acquired pneumonia. Emerg Med J 2004; 21: 446-8.
Flanders SA, Halm EA. Guidelines for community-acquired pneumonia: are they reflected in practice? Treat Respir Med 2004; 3: 67-77.
Schouten JA, Hulscher ME, Kullberg BJ, et al. Understanding variation in quality of antibiotic use for community-acquired pneumonia: effect of patient, professional and hospital factors. J Antimicrob Chem 2005; 56: 575-582.
Heffelfinger JD, Dowell SF, Jorgensen JH, et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000; 160: 1399-1408.
Genné D, Sommer R, Kaiser L, et al. Analysis of factors that contribute to treatment failure in patients with community-acquired pneumonia. Eur J Clin Microbiol Infect Dis 2006; 25: 159-166.
Menéndez R, Torres A, Zalacain R, et al. Risk factors of treatment failure in community-acquired pneumonia: implication for disease outcome. Thorax 2004; 59: 960-965.
Fine MJ, Auble TE, Yealy DM, et al. A prediction rule to identify low-risk patients with community-acquired pneumonia. N Engl J Med 1997; 336: 243-250.
Anevlavis S, Bouros D. Scoring systems in community acquired pneumonia. Pneumon 2009; 22:286-289.